tiprankstipranks
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
Germany Market
FME
Fresenius Medical Care AG & Co. KGaA
RESEARCH TOOLSreports
Want to see DE:FME full AI Analyst Report?

Fresenius Medical Care AG & Co. KGaA (FME) Stock Forecast & Price Target

21 Followers
See the Price Targets and Ratings of:

FME Analyst Ratings

Moderate Sell
11Ratings
Moderate Sell
1 Buy
5 Hold
5 Sell
Based on 11 analysts giving stock ratings to
Fresenius
Medical Care AG & Co. KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FME Stock 12 Month Forecast

Average Price Target

€38.24
▼(-1.16% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is €38.24 with a high forecast of €46.00 and a low forecast of €31.00. The average price target represents a -1.16% change from the last price of €38.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"30":"€30","49":"€49","34.75":"€34.8","39.5":"€39.5","44.25":"€44.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€46.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.239999999999995,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€38.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€31.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[30,34.75,39.5,44.25,49],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.4,37.138461538461534,37.87692307692308,38.61538461538461,39.353846153846156,40.09230769230769,40.83076923076923,41.56923076923077,42.30769230769231,43.04615384615384,43.784615384615385,44.52307692307692,45.261538461538464,{"y":46,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.4,36.54153846153846,36.68307692307692,36.824615384615385,36.966153846153844,37.107692307692304,37.24923076923076,37.39076923076923,37.53230769230769,37.67384615384615,37.81538461538461,37.956923076923076,38.098461538461535,{"y":38.239999999999995,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.4,35.98461538461538,35.56923076923077,35.15384615384615,34.738461538461536,34.323076923076925,33.90769230769231,33.49230769230769,33.07692307692307,32.66153846153846,32.246153846153845,31.83076923076923,31.415384615384614,{"y":31,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.463,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":46.924,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":41.616,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":42.347,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.539,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":44.77,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":39.145,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":39.193,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":36.635,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":38.308,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.106,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.126,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":36.4,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€46.00Average Price Target€38.24Lowest Price Target€31.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on DE:FME
Graham Doyle
UBS
UBS
€37
Sell
-4.37%
Downside
Reiterated
06/25/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
J.P. Morgan Analyst forecast on DE:FME
David Adlington
J.P. Morgan
J.P. Morgan
€37.4
Sell
-3.33%
Downside
Reiterated
06/25/26
David Adlington Reiterates Sell on Fresenius Medical Care, Keeps $37.4 Price Target Amid Valuation and Margin Concerns
Bank of America Securities Analyst forecast on DE:FME
Anna Ractliffe
Bank of America Securities
Bank of America Securities
€32
Sell
-17.29%
Downside
Reiterated
06/23/26
Sell Rating Reaffirmed on Limited Earnings Visibility and Competitive Pressures; €32 Price Target Maintained
Goldman Sachs Analyst forecast on DE:FME
Richard Felton
Goldman Sachs
Goldman Sachs
€38→€43
Hold
11.14%
Upside
Reiterated
06/22/26
Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on DE:FME
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
05/08/26
Morgan Stanley Analyst forecast on DE:FME
Aisyah Noor
Morgan Stanley
Morgan Stanley
€34→€33
Sell
-14.71%
Downside
Reiterated
05/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Morgan Stanley
Deutsche Bank Analyst forecast on DE:FME
Falko Friedrichs
Deutsche Bank
Deutsche Bank
€42→€40
Hold
3.39%
Upside
Reiterated
05/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Deutsche Bank
Barclays Analyst forecast on DE:FME
Hassan Al-Wakeel
Barclays
Barclays
€46.5→€46
Hold
18.89%
Upside
Reiterated
05/05/26
Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Jefferies Analyst forecast on DE:FME
James Vane
Jefferies
Jefferies
€32→€31
Sell
-19.88%
Downside
Reiterated
05/05/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Jefferies
Kepler Capital Analyst forecast on DE:FME
Oliver Reinberg
Kepler Capital
Kepler Capital
€43
Hold
11.14%
Upside
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi Analyst forecast on DE:FME
Veronika Dubajova
Citi
Citi
€39.5→€40
Hold
3.39%
Upside
Reiterated
04/24/26
Fresenius Medical price target raised to EUR 40 from EUR 39.50 at CitiFresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi
mwb research Analyst forecast on DE:FME
Harald Hof
mwb research
mwb research
€46→€47
Buy
21.48%
Upside
Upgraded
01/12/26
Berenberg Bank Analyst forecast on DE:FME
Sam England
Berenberg Bank
Berenberg Bank
€60
Buy
55.08%
Upside
Reiterated
12/03/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank
Bernstein Analyst forecast on DE:FME
Lisa Bedell Clive
Bernstein
Bernstein
€54.5
Hold
40.86%
Upside
Reiterated
10/20/25
Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on DE:FME
Graham Doyle
UBS
UBS
€37
Sell
-4.37%
Downside
Reiterated
06/25/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
J.P. Morgan Analyst forecast on DE:FME
David Adlington
J.P. Morgan
J.P. Morgan
€37.4
Sell
-3.33%
Downside
Reiterated
06/25/26
David Adlington Reiterates Sell on Fresenius Medical Care, Keeps $37.4 Price Target Amid Valuation and Margin Concerns
Bank of America Securities Analyst forecast on DE:FME
Anna Ractliffe
Bank of America Securities
Bank of America Securities
€32
Sell
-17.29%
Downside
Reiterated
06/23/26
Sell Rating Reaffirmed on Limited Earnings Visibility and Competitive Pressures; €32 Price Target Maintained
Goldman Sachs Analyst forecast on DE:FME
Richard Felton
Goldman Sachs
Goldman Sachs
€38→€43
Hold
11.14%
Upside
Reiterated
06/22/26
Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on DE:FME
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
05/08/26
Morgan Stanley Analyst forecast on DE:FME
Aisyah Noor
Morgan Stanley
Morgan Stanley
€34→€33
Sell
-14.71%
Downside
Reiterated
05/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Morgan Stanley
Deutsche Bank Analyst forecast on DE:FME
Falko Friedrichs
Deutsche Bank
Deutsche Bank
€42→€40
Hold
3.39%
Upside
Reiterated
05/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Deutsche Bank
Barclays Analyst forecast on DE:FME
Hassan Al-Wakeel
Barclays
Barclays
€46.5→€46
Hold
18.89%
Upside
Reiterated
05/05/26
Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Jefferies Analyst forecast on DE:FME
James Vane
Jefferies
Jefferies
€32→€31
Sell
-19.88%
Downside
Reiterated
05/05/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Jefferies
Kepler Capital Analyst forecast on DE:FME
Oliver Reinberg
Kepler Capital
Kepler Capital
€43
Hold
11.14%
Upside
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi Analyst forecast on DE:FME
Veronika Dubajova
Citi
Citi
€39.5→€40
Hold
3.39%
Upside
Reiterated
04/24/26
Fresenius Medical price target raised to EUR 40 from EUR 39.50 at CitiFresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi
mwb research Analyst forecast on DE:FME
Harald Hof
mwb research
mwb research
€46→€47
Buy
21.48%
Upside
Upgraded
01/12/26
Berenberg Bank Analyst forecast on DE:FME
Sam England
Berenberg Bank
Berenberg Bank
€60
Buy
55.08%
Upside
Reiterated
12/03/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank
Bernstein Analyst forecast on DE:FME
Lisa Bedell Clive
Bernstein
Bernstein
€54.5
Hold
40.86%
Upside
Reiterated
10/20/25
Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

3 Months
James VaneJefferies
Success Rate
22/50 ratings generated profit
44%
Average Return
-3.43%
Copying James Vane's trades and holding each position for 3 Months would result in 44.00% of your transactions generating a profit, with an average return of -3.43% per trade.
1 Year
James VaneJefferies
Success Rate
25/50 ratings generated profit
50%
Average Return
-3.67%
Copying James Vane's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -3.67% per trade.
2 Years
James VaneJefferies
Success Rate
19/50 ratings generated profit
38%
Average Return
-8.18%
Copying James Vane's trades and holding each position for 2 Years would result in 38.00% of your transactions generating a profit, with an average return of -8.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FME Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
2
2
1
2
1
Hold
11
14
10
10
8
Sell
16
15
11
11
13
Strong Sell
0
0
0
0
0
total
29
31
22
23
22
In the current month, FME has received 1 Buy Ratings, 8 Hold Ratings, and 13 Sell Ratings. FME average Analyst price target in the past 3 months is 38.24.
Each month's total comprises the sum of three months' worth of ratings.

FME Financial Forecast

FME Earnings Forecast

Next quarter’s earnings estimate for FME is €1.04 with a range of €0.87 to €1.30. The previous quarter’s EPS was €0.91. FME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.
Next quarter’s earnings estimate for FME is €1.04 with a range of €0.87 to €1.30. The previous quarter’s EPS was €0.91. FME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.

FME Sales Forecast

Next quarter’s sales forecast for FME is €4.74B with a range of €4.63B to €4.83B. The previous quarter’s sales results were €4.61B. FME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.
Next quarter’s sales forecast for FME is €4.74B with a range of €4.63B to €4.83B. The previous quarter’s sales results were €4.61B. FME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.

FME Stock Forecast FAQ

What is DE:FME’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 38.24.
    What is DE:FME’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:FME, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
        Fresenius Medical Care AG & Co. KGaA has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 5 hold ratings and 5 sell ratings.
          What is Fresenius Medical Care AG & Co. KGaA’s share price target?
          The average share price target for Fresenius Medical Care AG & Co. KGaA is 38.24. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €46.00 ,and the lowest forecast is €31.00. The average share price target represents -1.16% Decrease from the current price of €38.69.
            What do analysts say about Fresenius Medical Care AG & Co. KGaA?
            Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
              To buy shares of DE:FME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.